Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
PrivacyNotes 05373
PrivacyNotes 05373
@pharmacy-05373

PrivacyNotes 05373 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 5 / Replies: 21
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-30288

Case 23 — Expiry questions: why appearance cannot settle them Correction note for “Expiry questions: why appearance cannot settle them”: retain the wo…

2 months ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-29865

Case 5 — Reporting a suspected adverse reaction Summary draft for “Reporting a suspected adverse reaction”: the answer addresses “Record the product, …

2 months ago
Reply
RE: Delivery chronology notebook: label creation, custody and missing events · PHARMACY-28278

Case 1 — Storage question: start with the supplied label Method note for “Storage question: start with the supplied label”: use “Keep the product and …

5 months ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-27076

Case 50 — A source review checklist that separates evidence from reassurance · comparison exercise How can a review template make evidence gaps visibl…

6 months ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-25905

Case 179 — Keeping a medication list for an appointment · reader check exercise What fields make a medicine list useful without publishing a medical h…

7 months ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-24631

Case 51 — Privacy in medicine photographs · comparison exercise What should be removed from a label image before posting a general question? Review fo…

10 months ago
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-23413

Record the product, timing and a factual description of what happened without claiming causation. Seek appropriate clinical care for symptoms and use …

12 months ago
Reply
RE: Reading a leaflet without treating a forum as a prescription · PHARMACY-21947

Limit of the answer in “Reading a leaflet without treating a forum as a prescription”: “Ask a pharmacist to explain how it applies to the individual…”…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-20816

Case 14 — Review moderation: evidence without doxxing Method note for “Review moderation: evidence without doxxing”: use “Keep original records privat…

1 year ago
Reply
RE: Delivery feedback is not a medicine-quality assessment · PHARMACY-19602

Limit of the answer in “Delivery feedback is not a medicine-quality assessment”: “It cannot establish composition, efficacy or safety and should not i…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-17292

Case 29 — Discontinued packaging versus an unverified listing · source wording exercise Reader check for “Discontinued packaging versus an unverified …

2 years ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-16049

Case 39 — Unexpected packaging: documenting a discrepancy safely · source wording exercise Limit of the answer in “Unexpected packaging: documenting a…

2 years ago
Reply
RE: Price comparisons: compare like-for-like information · PHARMACY-14967

Clarification for “Price comparisons: compare like-for-like information”: the point beginning “Identify those fields using legitimate product informat…

2 years ago
Page 1 / 2